A clinical dosimetric perspective uncovers new evidence and offers new insight in favor of 99mTc-macroaggregated albumin for predictive dosimetry in 90Y resin microsphere radioembolization
- PMID: 24198389
- DOI: 10.2967/jnumed.113.128553
A clinical dosimetric perspective uncovers new evidence and offers new insight in favor of 99mTc-macroaggregated albumin for predictive dosimetry in 90Y resin microsphere radioembolization
Comment in
-
Reply: A clinical dosimetric perspective uncovers new evidence and offers new insight in favor of 99mTc-macroaggregated albumin for predictive dosimetry in 90Y resin microsphere radioembolization.J Nucl Med. 2013 Dec;54(12):2192-3. doi: 10.2967/jnumed.113.132852. Epub 2013 Nov 6. J Nucl Med. 2013. PMID: 24198388 No abstract available.
Comment on
-
99mTc-macroaggregated albumin poorly predicts the intrahepatic distribution of 90Y resin microspheres in hepatic radioembolization.J Nucl Med. 2013 Aug;54(8):1294-301. doi: 10.2967/jnumed.112.117614. Epub 2013 Jun 7. J Nucl Med. 2013. PMID: 23749996
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources